The predictive value and evolution of N-terminal pro-B-type natriuretic peptide levels following transcutaneous aortic valve implantation.

@article{Spargias2011ThePV,
  title={The predictive value and evolution of N-terminal pro-B-type natriuretic peptide levels following transcutaneous aortic valve implantation.},
  author={Konstantinos S Spargias and Spyros Polymeros and Antonis Dimopoulos and Athanassios Manginas and Gregory S Pavlides and Marina P Balanika and Anna Smirli and George T. Stavridis and George D Dangas and Dennis Vassilios Cokkinos},
  journal={Journal of interventional cardiology},
  year={2011},
  volume={24 5},
  pages={462-9}
}
AIMS We sought to define the predictive value and evolution of N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels following transcutaneous aortic valve implantation (TAVI). METHODS AND RESULTS We investigated 91 consecutive patients who underwent TAVI (59 transfemoral [TF], 32 transapical [TA]) in our institution. The balloon-expandable valve was implanted in 75 and the self-expanding in 16 patients. The baseline (within 48 hours prior to procedure), early (24-74 hours), and late (3… CONTINUE READING